Wealthspire Advisors (New York)’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$14.3M Buy
15,510
+2,699
+21% +$2.74M 0.11% 91
2025
Q4
$13.8M Buy
12,811
+4,787
+60% +$4.58M 0.11% 92
2025
Q3
$6.12M Sell
8,024
-8,610
-52% -$6.41M 0.03% 147
2025
Q2
$13M Sell
16,634
-64
-0.4% -$49.7K 0.07% 96
2025
Q1
$13.8M Buy
16,698
+7,989
+92% +$6.65M 0.08% 96
2024
Q4
$6.72M Buy
8,709
+1,672
+24% +$1.38M 0.07% 129
2024
Q3
$6.23M Buy
7,037
+1,325
+23% +$1.19M 0.06% 132
2024
Q2
$5.17M Sell
5,712
-287
-5% -$230K 0.07% 113
2024
Q1
$4.67M Sell
5,999
-405
-6% -$288K 0.06% 115
2023
Q4
$3.73M Buy
6,404
+451
+8% +$263K 0.05% 130
2023
Q3
$3.2M Buy
5,953
+2,319
+64% +$1.19M 0.05% 130
2023
Q2
$1.7M Sell
3,634
-104
-3% -$43.6K 0.03% 168
2023
Q1
$1.28M Sell
3,738
-2,041
-35% -$688K 0.02% 208
2022
Q4
$2.11M Buy
5,779
+1,808
+46% +$641K 0.04% 149
2022
Q3
$1.28M Buy
3,971
+1,276
+47% +$404K 0.03% 190
2022
Q2
$874K Buy
2,695
+663
+33% +$199K 0.02% 228
2022
Q1
$582K Sell
2,032
-3,594
-64% -$925K 0.01% 251
2021
Q4
$1.55M Sell
5,626
-825
-13% -$209K 0.03% 172
2021
Q3
$1.49M Buy
6,451
+3,981
+161% +$983K 0.03% 200
2021
Q2
$567K Sell
2,470
-9,528
-79% -$1.91M 0.01% 211
2021
Q1
$2.24M Buy
11,998
+2,746
+30% +$537K 0.05% 165
2020
Q4
$1.56M Buy
9,252
+2,499
+37% +$373K 0.05% 158
2020
Q3
$1M Buy
6,753
+1,821
+37% +$282K 0.06% 125
2020
Q2
$810K Sell
4,932
-6,738
-58% -$1.03M 0.06% 117
2020
Q1
$1.62M Buy
11,670
+9,007
+338% +$1.24M 0.07% 145
2019
Q4
$350K Buy
2,663
+601
+29% +$69.7K 0.03% 129
2019
Q3
$231K Buy
+2,062
New +$230K 0.02% 143
2019
Q1
Sell
-865
Closed -$100K 471
2018
Q4
$100K Buy
+865
New +$96.6K 0.01% 112

Other funds holding LLY

Wealthspire Advisors (New York)'s LLY Position: Q1 2026 in Review

Wealthspire Advisors (New York) increased its Eli Lilly (LLY) stake by 21% in Q1 2026, buying an estimated $2.74M and bringing the position to 15,510 shares worth $14.3M. The position accounts for 0.11% of the portfolio, ranked #91.

Wealthspire Advisors (New York) first reported a position in LLY in Q4 2018 and has held it in 28 quarters since. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Wealthspire Advisors (New York) held 15,510 shares of Eli Lilly worth $14.3M as of Q1 2026.
  • Wealthspire Advisors (New York) bought 2,699 Eli Lilly shares in Q1 2026, an estimated $2.74M.
  • Eli Lilly made up 0.11% of Wealthspire Advisors (New York)'s portfolio in Q1 2026, its #91 holding.
  • Wealthspire Advisors (New York) first reported a position in Eli Lilly in Q4 2018 and has held it in 28 quarters since.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Wealthspire Advisors (New York)'s 13F filing for Q1 2026, filed 1 May 2026.